Gadolinium Toxicity

Home » Articles posted by Sharon Williams (Page 20)

Author Archives: Sharon Williams

Viewpoint Categories

We have an important advocate in Dr. Manny Kanal.

After years of trying to get the FDA and medical community’s attention about the issue of Gadolinium retention in patients with normal kidney function, it looks like our efforts have begun to pay off.

I want to share some news about Dr. Emanuel (Manny) Kanal.  If you aren’t familiar with his name, Dr. Kanal is a leading radiologist and someone the FDA looks to for advice on matters related to MRI Safety.  Duke and I have been in communication with him since October of 2013.

As you might imagine, MRI Safety is an important issue that requires medical professionals to stay well-informed about safety issues directly related to MR devices as well as the Gadolinium-based Contrast Agents administered for contrast-enhanced MRI and MRA.  Since June of this year, Dr. Kanal has been conducting MRI Safety Officer (MRSO) and MRI Medical Director (MRMD) Seminars.

During a seminar on September 9, 2014, Dr. Kanal provided a “Gadolinium Contrast Overview”.  According to the MRI Patient Safety blog, besides describing the state of NSF, he described “new and growing concerns about non-NSF bio-retention”.  (more…)

Pain from Peripheral Neuropathy can be caused by metals like Gadolinium

When we conducted our Symptom Survey early in 2014, the one chronic symptom that everyone reported was “Pain”.  Some identified it as being an ache with dull, continuous pain, while others described it as burning, numbness, tingling, or prickling sensations (paresthesia), or as deep bone pain, or electric-like feelings.  The location of the pain was primarily in the extremities, followed by the hips, joints, and ribs.

From my own experience, I can tell you that I always have some level of pain even with taking prescription medication.  While stronger medications might make me feel pain free, I prefer to live with a tolerable level of pain rather than feel over-medicated.

From what I have read, it seems that most of our pain is the result of damage to our nervous system. (more…)

Mast Cells and Gadolinium Toxicity, is there a connection?

In the summer of 2012, I was asked if I had ever read anything about mast cells and Gadolinium or NSF.  I vaguely remembered mast cells being mentioned in one study, but it obviously didn’t strike me as being important or I would have done some research on it then.  But after digging around a bit, I came away thinking that there might be a connection between mast cells and the disease progression of NSF/GASF.

For those who don’t know, mast cells are found in tissues throughout the body, particularly in association with structures such as blood vessels, peripheral nerves, in mucosal membranes, skin and subcutaneous tissue.  Mast cells are bone marrow-derived and particularly dependent upon stem cell factor for their survival.  They express a variety of phenotypic features within tissues that are determined by their local environment.  Mast cells appear to be highly engineered cells with multiple critical biological functions.  (more…)

Study reports brain abnormalities on MRI in patients with normal kidney function

In the October 2014 issue of Investigative Radiology, Errante et al report study findings that confirm the association between the increase in the unenhanced T1-weighted signal intensity of the dentate nucleus and the number of gadolinium-enhanced MRI scans.  (The dentate nucleus is located within the deep white matter of the brain.)

The study included 38 patients with Multiple Sclerosis (MS) and 37 patients with brain metastases (BMs) who had undergone at least 2 consecutive enhanced MRIs.  After calculating the dentate nuclei-to-pons (DNP) signal intensity ratio, these values were compared between patients with less than 6 and those with 6 or more contrast-enhanced MRI.  A progressive increase in the T1 signal intensity of the DNP ratio was observed in both the MS group and the BM group.  All patients had normal kidney function. (more…)